Researchers have developed an "Alzheimer's clock" that uses a blood test to predict when symptom onset is likely in cognitively unimpaired individuals based on levels of p-tau217; this model could enable earlier intervention and treatment for Alzheimer's disease, offering hope for improved patient outcomes.
Read the full article at MedPage Today
This is a brief trending article summary.
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.



